Drug to Treat HIV in Children Shows Promise Via National Clinical Trial
For children and adolescents with HIV infection, the recent Food and Drug Administration (FDA) approval of the use of raltegravir, an antiretroviral drug that slows the spread of HIV infection, offers a new weapon to treat HIV infection in children. So says Sharon Nachman, M.D., Associate Dean for Research and Professor of Pediatrics, Stony Brook University School of Medicine, and the Principal Investigator and Study Chair of a national multicenter clinical trial that studied the safety and efficacy of raltegravir in HIV-infected children and adolescents.
Notes
-
bonedust liked this
-
koiandhoney liked this
-
ancopcanadabc reblogged this from caraobrien
-
caraobrien posted this
